Show simple item record

dc.creatorGođevac, Dejan
dc.creatorTešević, Vele
dc.creatorVajs, Vlatka
dc.creatorMilosavljević, Slobodan
dc.creatorStanković, Miroslava
dc.date.accessioned2019-01-30T17:37:55Z
dc.date.available2019-01-30T17:37:55Z
dc.date.issued2013
dc.identifier.issn1389-5575
dc.identifier.urihttp://cer.ihtm.bg.ac.rs/handle/123456789/1353
dc.description.abstractThis article summarizes the results of using cytokinesis-block micronucleus (CBMN) assay to evaluate the antioxidant potential of heterocyclic compounds. Most studies were carried out with naturally occurring heterocyclic compounds such as plant polyphenols: flavonoids, xanthones, coumarins, and ellagitannins, or plant derived products (juices, extracts, supplements) rich in bioactive heterocyclic compounds. There are also some studies dealing with synthetic heterocyclic antioxidants. CBMN assay is an in vitro study that has been used to evaluate antioxidant and protective effects of heterocyclic compounds on induced chromosome aberration in human lymphocytes.en
dc.publisherBentham Science Publ Ltd, Sharjah
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172053/RS//
dc.rightsrestrictedAccess
dc.sourceMini-Reviews in Medicinal Chemistry
dc.subjectAntioxidantsen
dc.subjectCBMN assayen
dc.subjectHeterocyclic compoundsen
dc.subjectHuman lymphocytes DNAen
dc.titleAntioxidant Evaluation of Heterocyclic Compounds by Cytokinesis-Block Micronucleus Assayen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractМилосављевиц, Слободан; Станковиц, Мирослава; Вајс, Влатка; Гођевац, Дејан; Тесевиц, Веле;
dc.citation.volume13
dc.citation.issue3
dc.citation.spage431
dc.citation.epage438
dc.citation.other13(3): 431-438
dc.citation.rankM21
dc.identifier.pmid23061623
dc.identifier.doi10.2174/138955713804999856
dc.identifier.rcubConv_2954
dc.identifier.scopus2-s2.0-84876829148
dc.identifier.wos000317206800010
dc.type.versionpublishedVersion


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record